Mural Health and ICON plc are partnering up to advance a shared mission to remove financial barriers to trial participation. Utilizing the Mural Link platform, ICON will benefit from the elimination of significant financial friction points for patients and sites to participate in trials and increase the total recruitable participant population, including from historically underrepresented groups.
Mural Link includes functionality that will support ICON’s clinical trials through:
- Clinical trial participant payments
- Tax management
- Travel and concierge support
- Site-participant communication tools
- Novel reporting and analytics capabilities
Sam Whitaker, CEO of Mural Health pointed to ICON’s commitment to patient care and innovation as one catalyst for the collaboration. “This partnership represents a shared vision of removing barriers to trial participation and advancing participation financial neutrality, while eliminating the need for site staff to manage highly manual, error-prone, and time-consuming administrative activities,” Whitaker said.
Read the full press release here.